漢達生技醫藥股份有限公司 (6620)
Total Capital
2,500,000,000
Paid-in Capital
1,659,819,000
Stock Listing Information
Monthly Revenue Info
Price Chart TPEX:6620
Chart by TradingView. Quotes may be delayed; for reference only, not investment advice. TradingView
財務報表與股價評價
收盤價 (2026-11-18)
101.50
-7.00
本益比
56.70
股價淨值比
3.27
殖利率
2.04%
損益表(累計,單位:新臺幣)
財報為年初至該季累計數字;每次僅能取得最新一期,歷史期間隨本站更新逐步累積。
資產負債(115 年 Q1~Q3)
總資產
52.2 億
總負債
1.8 億
權益總額
50.4 億
負債比率 / 流動比率
3.5% / 4,138%
每股淨值
31.03 元
股利政策
資料來源:臺灣證券交易所、證券櫃檯買賣中心、公開資訊觀測站;僅供參考,不構成投資建議。查看全部上市櫃財報排行
Registration Info
Representative
LIU FANG-YU(劉芳宇)
Address
臺南市新市區南科三路23號3樓之1、3樓之2
MapRegistration Date
2014/5/8
Last Update Date
2026/8/26
Business Items
MOEA Registered Items
MOF Tax Items
Business & Equity Network Graph
Links generated by name matching. Scroll to zoom. Click blue/purple nodes to view details.
Directors & Supervisors
| Title | Name | Shares Held | Representative For |
|---|---|---|---|
| 董事長 | LIU FANG-YU(劉芳宇) | 27,262,000 | 0 Liu Handa Holdings,LLC |
| 董事 | Chang, Mei Fang (張美芳) | 27,262,000 | 0 Liu Handa Holdings,LLC |
| 董事 | 陳俊良 | 27,262,000 | 0 Liu Handa Holdings,LLC |
| 董事 | 林衛理 | 27,262,000 | 0 Liu Handa Holdings,LLC |
| 董事 | 盧麗安 | 17,000,000 | 0 台灣神隆股份有限公司 |
| 董事 | 馬海怡 | 21,000 | |
| 獨立董事 | Wu, Jinn吳晉 | 0 | |
| 獨立董事 | 徐大誠 | 0 | |
| 獨立董事 | 周珮芬 | 0 |
Managers
| Title | Name | Onboard Date |
|---|---|---|
| No public manager data available. | ||
Equity Status
Equity Status
-
Foreign Investment
-
Foreign Company Name
-
Multiple Voting Preferred Shares
-
Veto Power Preferred Shares
-
Price Per Share (NTD)
-
Total Issued Shares
-
Registration Status
核准設立
Restrictions on Preferred Shareholders
-